|
02.05.2018 22:00:00
|
Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 43rd Annual Health Care Conference
DUBLIN, May 2, 2018 /PRNewswire/ -- Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday, May 9, 2018 at 10:00 a.m. ET (3:00 p.m. BST) from Boston. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Contact:
Jennifer Zibuda
Corporate Communications
+1 781 609 6129
Logo- https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alkermes PLCmehr Nachrichten
|
23.10.24 |
Ausblick: Alkermes stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
|
23.07.24 |
Ausblick: Alkermes präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu Alkermes PLCmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.